ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors.

Anthony El-Khoueiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.